vs
Dominari Holdings Inc.（DOMH）与Phathom Pharmaceuticals, Inc.（PHAT）财务数据对比。点击上方公司名可切换其他公司
Phathom Pharmaceuticals, Inc.的季度营收约是Dominari Holdings Inc.的1.9倍（$57.6M vs $30.1M），Dominari Holdings Inc.同比增速更快（220.4% vs 94.1%）
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
DOMH vs PHAT — 直观对比
营收规模更大
PHAT
是对方的1.9倍
$30.1M
营收增速更快
DOMH
高出126.3%
94.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $57.6M |
| 净利润 | $-131.8M | — |
| 毛利率 | — | 86.7% |
| 营业利润率 | -8.9% | — |
| 净利率 | -438.1% | — |
| 营收同比 | 220.4% | 94.1% |
| 净利润同比 | -12426.2% | 71.6% |
| 每股收益（稀释后） | $-6.94 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHPHAT
| Q4 25 | $30.1M | $57.6M | ||
| Q3 25 | $50.8M | $49.5M | ||
| Q2 25 | $34.1M | $39.5M | ||
| Q1 25 | $8.1M | $28.5M | ||
| Q4 24 | $9.4M | $29.7M | ||
| Q3 24 | $4.0M | $16.4M | ||
| Q2 24 | $6.2M | $7.3M | ||
| Q1 24 | $1.4M | — |
净利润DOMHPHAT
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $-30.0M | ||
| Q2 25 | $16.6M | $-75.8M | ||
| Q1 25 | $-32.5M | $-94.3M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | $-85.6M | ||
| Q2 24 | $-6.1M | $-91.4M | ||
| Q1 24 | $-5.4M | — |
毛利率DOMHPHAT
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
营业利润率DOMHPHAT
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | -30.8% | ||
| Q2 25 | -57.0% | -151.7% | ||
| Q1 25 | -394.6% | -276.5% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | -433.0% | ||
| Q2 24 | -44.3% | -1055.4% | ||
| Q1 24 | -205.2% | — |
净利率DOMHPHAT
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | -60.5% | ||
| Q2 25 | 48.7% | -191.9% | ||
| Q1 25 | -400.5% | -330.7% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | -523.3% | ||
| Q2 24 | -99.1% | -1248.6% | ||
| Q1 24 | -398.0% | — |
每股收益（稀释后）DOMHPHAT
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $-0.41 | ||
| Q2 25 | $1.12 | $-1.05 | ||
| Q1 25 | $-3.02 | $-1.31 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | $-1.32 | ||
| Q2 24 | $-1.01 | $-1.56 | ||
| Q1 24 | $-0.91 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $130.0M |
| 总债务越低越好 | — | $209.1M |
| 股东权益账面价值 | $69.4M | $-438.2M |
| 总资产 | $112.9M | $259.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHPHAT
| Q4 25 | $80.5M | $130.0M | ||
| Q3 25 | $176.2M | $135.2M | ||
| Q2 25 | $28.2M | $149.6M | ||
| Q1 25 | $18.9M | $212.3M | ||
| Q4 24 | $8.2M | $297.3M | ||
| Q3 24 | $7.2M | $334.7M | ||
| Q2 24 | $12.1M | $276.2M | ||
| Q1 24 | $7.1M | — |
总债务DOMHPHAT
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
股东权益DOMHPHAT
| Q4 25 | $69.4M | $-438.2M | ||
| Q3 25 | $210.2M | $-422.5M | ||
| Q2 25 | $88.6M | $-405.8M | ||
| Q1 25 | $42.4M | $-338.4M | ||
| Q4 24 | $39.9M | $-253.6M | ||
| Q3 24 | $38.3M | $-187.1M | ||
| Q2 24 | $42.4M | $-233.8M | ||
| Q1 24 | $47.7M | — |
总资产DOMHPHAT
| Q4 25 | $112.9M | $259.1M | ||
| Q3 25 | $223.4M | $240.3M | ||
| Q2 25 | $109.3M | $250.2M | ||
| Q1 25 | $52.3M | $294.2M | ||
| Q4 24 | $47.1M | $378.3M | ||
| Q3 24 | $43.4M | $387.0M | ||
| Q2 24 | $49.1M | $319.4M | ||
| Q1 24 | $52.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-166.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-167.0M |
| 自由现金流率自由现金流/营收 | — | -290.0% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-328.9M |
8季度趋势，按日历期对齐
经营现金流DOMHPHAT
| Q4 25 | $22.7M | $-166.8M | ||
| Q3 25 | $-4.9M | $-14.1M | ||
| Q2 25 | $-353.0K | $-62.7M | ||
| Q1 25 | $1.2M | $-84.9M | ||
| Q4 24 | $-16.7M | $-266.8M | ||
| Q3 24 | $-4.7M | $-63.6M | ||
| Q2 24 | $1.4M | $-70.7M | ||
| Q1 24 | $-8.6M | — |
自由现金流DOMHPHAT
| Q4 25 | — | $-167.0M | ||
| Q3 25 | — | $-14.1M | ||
| Q2 25 | — | $-62.8M | ||
| Q1 25 | — | $-84.9M | ||
| Q4 24 | — | $-266.9M | ||
| Q3 24 | — | $-63.6M | ||
| Q2 24 | — | $-70.8M | ||
| Q1 24 | — | — |
自由现金流率DOMHPHAT
| Q4 25 | — | -290.0% | ||
| Q3 25 | — | -28.6% | ||
| Q2 25 | — | -159.0% | ||
| Q1 25 | — | -297.9% | ||
| Q4 24 | — | -899.8% | ||
| Q3 24 | — | -389.0% | ||
| Q2 24 | — | -966.2% | ||
| Q1 24 | — | — |
资本支出强度DOMHPHAT
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | — |
现金转化率DOMHPHAT
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
PHAT
暂无分部数据
